|
|||||||
|
Etanercept, marketed under the name Enbrel, is a drug that belongs to the class of drugs known as tumor necrosis factor (TNF)-alpha blocker. It is used primarily to treat rheumatoid arthritis, but has also been approved for use in treating polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and psoriasis. On May 1st, the [...] Several studies have been conducted into to effectiveness of the newest class of drugs, tumor necrosis factor (TNF)-alpha blockers, in treating rheumatoid arthritis. But there have been no published studies comparing TNF-alpha blockers with the older class of drugs, known as disease-modifying anti-rheumatic drugs (DMARDS), such as Remicade (infliximab), Enbrel (etanercept), and Humira (adalimumab). [...]
Traffic A new study suggests that people who are exposed to high levels of pollution from traffic have an increased risk of rheumatoid arthritis. Researchers performed an analysis of records from 90,000 women in the Nurses Health Study and utilized unique software to measure the distance between each of the woman’s homes and [...] Rose hips (or rosehips) are the bright red fruit of the rosa canina, or wild rose bush. The rosa canina, or Dog Rose, is a scrambling rose species which is native to western Asia, northwest Africa and Europe. It has been used to make syrup, herbal tea and marmalade and is used in dietary [...] Arthritis is the name for a group of conditions that exhibit damage to joints such as knees, hips and fingers. According to the Arthritis Foundation there are over 100 different conditions covered by the term “arthritis”, the most common being osteoarthritis and rheumatoid arthritis. Depending of the form of arthritis the initial symptoms of [...] According to a recently released study, and maybe common sense and logic, people with arthritis or fibromyalgia frequently have discomfort or problems using computers. This can contribute to work limitations. Nancy A. Baker, of the University of Pittsburgh in Pennsylvania, and team performed an analysis of data from 359 participants with rheumatoid arthritis, osteoarthritis, [...] Biogen Idec Inc. announced on October 9th that it was discontinuing development of its investigational rheumatoid arthritis (RA) drug baminercept after if failed to meet Phase II study endpoints. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
